Similarly, we found that the expression patterns of MYC, BCL2, double expression of MYC and BCL2, p53, and CD5 were not associated with OS in patients with WR‐DLBCL, SN‐DLBCL, or LN‐DLBCL (Table S1). This evidence concerns the gene BCL2 and diffuse large B-cell lymphoma.